Sentence examples for iv week from inspiring English sources

A distinguishing delay in tumor formation was noted in mice treated with 30 mg/kg TQF (group V, week 11) and 10 mg/kg TQF (group IV, week 14).

Behavioural support was provided in the usual style at each clinic, involving seven weekly, mainly group support, sessions (each 60 90 min) over 6 weeks: (i) assessment/screening, (ii) preparation, (iii) quit-day, (iv) week 1 post-quit, (v) week 2 post-quit, (vi) week 3 post-quit and (vii) week 4 post-quit 10, 11.

The rehabilitation program consisted in: during the I-II weeks loading according the pain, isometric contraction of the quadriceps three times a day, flection 0°-90° 0°-90°a day using a CPM device (Contwiceus Passive Motion) andaylexors stretching; dusing III-IV weeks were added isotoniCPMontraction of the quadevices 0°-30° and aContinuousive flection 0°-120° (III-IV week) and 0°-135° (V-VI week).

The mice were then killed 1 (Group-II), 4 (Group-III), or 8 (Group-IV) weeks (w) after the final injection.

Patients failing to collect medication were categorized into four groups based on the duration of the delay: i) ≥6 weeks ii) ≥12 weeks and iii) ≥18 weeks and iv) ≥24 weeks.

The results show that A1C levels were higher in groups III (29 32 weeks) and IV (33 36 weeks) than in groups I (21 24 weeks) and II (25 28 weeks).

RESEARCH DESIGN AND METHODS In study 1, A1C, serum glycated albumin, erythrocyte indexes, and iron metabolism indexes were determined in 47 nondiabetic pregnant women not receiving iron supplementation who were divided into four groups according to gestational period (group I, 21 24 weeks; group II, 25 28 weeks; group III, 29 32 weeks; and group IV, 33 36 weeks).

The following phase-II trials evaluated rituximab (375 mg/m IV per week for a minimum of 4 consecutive weeks) as initial therapy in patients with FL.

Two years later, his anaemia became refractory to high-dose darbepoetin therapy (200 μg IV a week).

The median response duration in stage IIIB was 34 weeks (range 20 54 weeks) and in stage IV 26 weeks (range 14 38 weeks).

They received 3 mg/kg infliximab IV at weeks 0, 2 and 6 and every 8 weeks thereafter in combination with methotrexate.